XML 22 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating Activities:    
Net income (loss) attributable to common stockholders $ 38,558 $ (43,428)
Net income (loss) attributable to non-controlling interests 4,477 2,038
Net income (loss) 43,035 (41,390)
Adjustments to reconcile net income to net cash provided by (used in) operating activities    
Net realized and unrealized (gains) losses (120,268) (6,628)
Net (gain) loss on sale of businesses 1,175 0
Non-cash compensation expense 3,717 6,158
Amortization/accretion of premiums and discounts 2,134 1,614
Depreciation and amortization expense 18,261 12,244
Non-cash lease expense 6,520 5,196
Dividend reinvestment plan income 0 (953)
Amortization of deferred financing costs 1,176 608
Loss on extinguishment of debt 0 353
Deferred provision (benefit) for income taxes 10,777 (2,841)
Other 133 192
Changes in operating assets and liabilities:    
Mortgage loans originated for sale (2,100,276) (2,104,377)
Proceeds from the sale of mortgage loans originated for sale 2,184,852 2,164,731
(Increase) decrease in notes and accounts receivable (57,859) (50,399)
(Increase) decrease in reinsurance receivables (99,190) (35,401)
(Increase) decrease in deferred acquisition costs (123,510) (37,903)
(Increase) decrease in other assets 337 (17,773)
Increase (decrease) in unearned premiums 192,430 37,540
Increase (decrease) in policy liabilities and unpaid claims 80,176 15,528
Increase (decrease) in deferred revenue 112,062 81,565
Increase (decrease) in reinsurance payable 14,839 18,556
Increase (decrease) in other liabilities and accrued expenses 15,518 21,595
Net cash provided by (used in) operating activities 186,039 68,215
Investing Activities:    
Purchases of investments (1,251,741) (1,053,359)
Proceeds from sales and maturities of investments 1,064,915 988,594
Proceeds from the sale of real estate 0 1,266
Purchases of property, plant and equipment (2,103) (4,709)
Proceeds from the sale of businesses 125 375
Proceeds from notes receivable 40,337 30,290
Issuance of notes receivable (52,957) (48,787)
Business and asset acquisitions, net of cash, restricted cash and deposits [1] 133 20,900
Net cash provided by (used in) investing activities (201,291) (65,430)
Financing Activities:    
Dividends paid (4,020) (4,199)
Non-controlling interest contributions 100 0
Non-controlling interest redemptions (1,484) (1,907)
Payment of debt issuance costs (62) (3,640)
Proceeds from borrowings and mortgage notes payable 2,265,796 2,382,569
Principal paydowns of borrowings and mortgage notes payable (2,257,947) (2,330,395)
Repurchases of common stock (2,882) (9,165)
Net cash provided by (used in) financing activities (499) 33,263
Net increase (decrease) in cash, cash equivalents and restricted cash (15,751) 36,048
Cash, cash equivalents and restricted cash – beginning of period 195,275 144,590
Cash, cash equivalents and restricted cash – beginning of period - held for sale 4,879 7,137
Cash, cash equivalents and restricted cash – end of period 184,403 187,775
Less: Reclassification of cash to assets held for sale 12,319 6,178
Cash, cash equivalents and restricted cash – end of period 172,084 181,597
Supplemental Schedule of Non-Cash Investing and Financing Activities:    
Right of use asset obtained in exchange for lease liability 3,046 1,109
Equity securities acquired as part of a dividend reinvestment plan 0 953
Shares issued in exchange for vested subsidiary awards 659 0
Reconciliation of cash, cash equivalents and restricted cash    
Cash and cash equivalents 150,496  
Restricted cash 21,588  
Total cash, cash equivalents and restricted cash shown in the statements of cash flows $ 172,084 $ 181,597
[1] Changes in balance sheet balances due to acquisitions have been netted down in the respective line items. See Note (3) Acquisitions for additional information.